Clinical Trials Sponsored by Staidson (Beijing) Biopharmaceuticals Co., Ltd

Total 1129 results

Xiaoming Gong

Completed

Phase II Trial of VDJ001 in Patients With Moderate-to-severe Active Rheumatoid Arthritis

Rheumatoid Arthritis

China
Beijing InnoCare Pharma Tech Co., Ltd.

Active, not recruiting

A Study of Tyrosine Kinase Inhibitor Orelabrutinib (ICP-022) in Patients With r/r B-Cell Malignancies

Part 1：r/r B-cell Malignancies | Part 2：B-cell Malignancies

United States, Poland, Israel, Ukraine
Beijing 3E-Regenacy Pharmaceuticals Co., Ltd.

Completed

Pre-study to Evaluate IENFD Induction in Patients With Taxane-induced CIPN

Peripheral Nervous System Diseases

China
Beijing InnoCare Pharma Tech Co., Ltd.

Active, not recruiting

A Study to Evaluate ICP-022 in Patients With R/R PCNSL and SCNSL

PCNSL | Secondary Central Nervous System Lymphoma

China
Beijing InnoCare Pharma Tech Co., Ltd.

Completed

A Phase I Randomized, Double-Blind, Placebo-Controlled, Parallel Group Clinical Study of ICP-332 in Healthy Subjects

Healthy Subjects

China
Beijing InnoCare Pharma Tech Co., Ltd.

Active, not recruiting

A Study to Evaluate ICP-022 in Patients With CLL/ SLL

CLL/SLL

China
Beijing InnoCare Pharma Tech Co., Ltd.

Completed

Study of ICP-105 in Solid Tumors Patients

Solid Tumor

China
Beijing Sanwater Biological Technology Co., Ltd.

Unknown

Efficacy of CART-19 Cell Therapy in B Cell Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia

China
Beijing Bozhiyin T&S Co., Ltd.

Unknown

A Clinical Trial of Danhong Injection in Treating Acute Ischemic Stroke

Stroke
Beijing Bozhiyin T&S Co., Ltd.

Unknown

Study of Dexamethasone-Allantoin-Metronidazole (DAM) Solution in the Treatment of Post-Operative Ileus (POI)

Postoperative Ileus

China
Xuanwu Hospital, Beijing
Beijing Haidian Hospital; BEIJING DNSYS INNOVATION Co. Ltd

Not yet recruiting

A Study of the Safety and Efficacy of Intelligent Powered Exoskeletons in Postoperative Spinal Rehabilitation

Exoskeleton Device
Geneplus-Beijing Co. Ltd.
Beijing Hospital; Emergency General Hospital

Recruiting

Benign/Malignant Pulmonary Nodule Classification Based on High-throughput Whole-genome Methylation Sequencing(GM-seq)

Pulmonary Nodule, Solitary | Whole-genome Methylation Sequencing

China
Beijing Huanxing Cancer Hospital
Newish Technology (Beijing) Co., Ltd.

Terminated

Autologous Cellular Immunotherapy in Patients With Metastatic Bladder Urothelial Carcinoma

Urinary Bladder Neoplasm

China
Zai Biopharmaceutical (Suzhou) Co., Ltd.

Completed

A Study of ZL-1211 in Patients With Advanced Solid Tumor

Advanced Solid Tumor

United States, China
Ark Biosciences Inc.
Shanghai Ark Biopharmaceutical Co., Ltd.

Not yet recruiting

A Study to Evaluate the Safety, Tolerability and Efficacy of AK3280 Cream on Hypertrophic Scar

Hypertrophic Scar

China
Ark Biosciences Inc.
Shanghai Ark Biopharmaceutical Co., Ltd.

Completed

A Study of AK3280 in Chinese Healthy Volunteers

Healthy

China
AskGene Pharma, Inc.
Suzhou Aosaikang Biopharmaceutical Co., Ltd.

Not yet recruiting

A Study of ASKG712 in Patients With Diabetic Macular Edema

Diabetic Macular Edema

China
AskGene Pharma, Inc.
Suzhou Aosaikang Biopharmaceutical Co., Ltd.

Recruiting

A Study of ASKG712 in Patients With Neovascular Age-Related Macular Degeneration

Neovascular Age-related Macular Degeneration

China
Ark Biosciences Inc.
Shanghai Ark Biopharmaceutical Co., Ltd.

Not yet recruiting

A Study to Evaluate the Efficacy and Safety of AK3280 in Patients With Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

China
Taipei City Hospital
The One Biopharmaceutical Co., Ltd.

Completed

Clinical Trials Using HepatoKeeper Herbal Essentials to Treat Non-alcoholic Fatty Liver Disease and Metabolic Factors

Non-alcoholic Fatty Liver Disease | Liver Fibrosis | Liver Injury

Taiwan
Conjupro Biotherapeutics, Inc.
CSPC Megalith Biopharmaceutical Co., Ltd.

Withdrawn

Dose Escalation and Expansion Study of CPO102, an Anti-claudin 18.2 ADC in Patients With Advanced Cancers

Gastric Cancer | Pancreatic Cancer
Beijing Tiantan Hospital
Beijing GeneX Health Technology Co., Ltd

Recruiting

PTCs-based Precision Treatment Strategy on Recurrent High-grade Gliomas

Recurrent High Grade Glioma

China
Beijing Tiantan Hospital
Beijing Bionovo Medicine Development Co., Ltd.

Completed

A Safety and Effective Study of Ginkgolides Diterpene Lactone Meglumine Injection in the Treatment of Ischemic Stroke.

Ischemic Stroke

China
Sichuan Kelun Pharmaceutical Research Institute...
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Recruiting

A Phase III Study of SKB264 for EGFR Mutant NSCLC Patients

Non-small Cell Lung Cancer

China
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Recruiting

SKB264 +/- KL-A167 in Recurrent or Metastatic HER2-negative Breast Cancer

Triple-negative Breast Cancer and HR+/HER2- BC

China
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Active, not recruiting

KL-A167 Injection Combined With Cisplatin and Gemcitabine vs Placebo Combined With Cisplatin and Gemcitabine in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma | Recurrent or Metastatic

China
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Completed

KL-A167 Injection in Recurrent or Metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma | Recurrent or Metastatic

China
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Completed

An Open, Multicenter Phase II Study to Evaluate the Safety and Efficacy of KL-A167 Injection in Relapsed or Refractory Classical Hodgkin's Lymphoma

Classical Hodgkin Lymphoma

China
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Not yet recruiting

A Study of SKB264 Versus Investigator's Choice Chemotherapy in Patients With Unresectable Recurrent or Metastatic Triple-Negative Breast Cancer

Triple Negative Breast Cancer

China
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Active, not recruiting

SKB264 Injection vs Investigator Selected Regimens to Treat Locally Advanced, Recurrent or Metastatic Triple-negative Breast Cancer

Triple Negative Breast Cancer

China
Jiangsu Kanion Pharmaceutical Co., Ltd
Beijing Bionovo Medicine Development Co., Ltd.

Completed

A Pilot Study for Ginkgolides Meglumine Injection Skin Testing.

Allergy

China
DK Medical Technology (Suzhou) Co., Ltd.
Core Medical (Beijing) Co., Ltd.

Active, not recruiting

A Safety and Efficacy Study of Dissolve™ in Treatment of Coronary Small Vessel Disease

Coronary Small Vessel Disease

China
DK Medical Technology (Suzhou) Co., Ltd.
Core Medical (Beijing) Co., Ltd.

Active, not recruiting

A Safety and Efficacy Study of Dissolve™ in Treatment of Coronary In-stent Restenosis

Coronary In-stent Restenosis

China
Jiangsu Kanion Pharmaceutical Co., Ltd
Beijing Bionovo Medicine Development Co., Ltd.

Completed

A Randomized, Placebo-Controlled, Double-blind Study of Tianshu Capsule in the Treatment of Migraine.

Migraine

China
Jiangsu Kanion Pharmaceutical Co., Ltd
Beijing Bionovo Medicine Development Co., Ltd.

Completed

A Safety Study of Ginkgolides Meglumine Injection in the Treatment of Ischemic Stroke.

Ischemic Stroke

China
Jiangsu Kanion Pharmaceutical Co., Ltd
Beijing Bionovo Medicine Development Co., Ltd.

Unknown

Multi-center Clinical Trials of Sanjie Analgesic Capsule in Treating Endometriosis

Dysmenorrhea

China
Jiangsu Kanion Pharmaceutical Co., Ltd
Beijing Bionovo Medicine Development Co., Ltd.

Completed

Preliminary Study of Pharmacokinetics of Ginkgolides Meglumine Injection.

Ischemic Stroke

China
Rise Biopharmaceuticals, Inc.
T-TOP Clinical Research Co., Ltd.

Recruiting

RP72 Monotherapy and in Combination With Gemcitabine in Patients With Pancreatic Cancer

Pancreatic Cancer | Pancreatic Cancer Metastatic | Pancreatic Cancer Non-resectable

Taiwan
Shenzhen Kangtai Biological Products Co., LTD
Beijing Minhai Biotechnology Co., Ltd

Not yet recruiting

A Study to Evaluate the Efficacy, Safety and Immunogenicity of SARS-CoV-2 Vaccine (Vero Cells), Inactivated in Healthy Adults Aged 18 Years and Older (COVID-19)

COVID-19
Guizhou Tongjitang Pharmaceutical Co.,Ltd
Beijing Bionovo Medicine Development Co., Ltd.

Unknown

Efficacy and Safety of Runzao Zhiyang Capsule to Treat Chronic Eczema

Chronic Eczema

China
Chongqing Fortune Pharmaceutical Co., Ltd.
Beijing Bionovo Medicine Development Co., Ltd.

Completed

Clinical Trial of Rasagiline in Levodopa-Treated Parkinson's Disease Patients With Motor Fluctuations

Parkinson´s Disease

China
Suzhou Kintor Pharmaceutical Inc,
Jiangsu Alphamab Biopharmaceuticals Co., Ltd

Recruiting

A Phase Ib/II Study of GT90001 Combined With KN046 in Solid Tumors

Solid Tumor

Taiwan
Hengenix Biotech Inc
Sanyou Biopharmaceuticals(Shanghai)Co., Ltd; Shanghai ZJ Bio-Tech Co., Ltd

Withdrawn

Evaluate Safety and Pharmacokinetics of HLX70 in Healthy Adult Volunteers

COVID 19
Beijing YouAn Hospital
Beijing Gene Key Life Technology Co., Ltd.

Recruiting

Adoptive Autologous iNKT Cells for the Treatment of Progressed Hepatocellular Carcinoma Continuing on PD-1 Inhibitor Therapy

Hepatocellular Carcinoma

China
Jiuzhitang Maker (Beijing) Cell Technology Co.,Ltd...
Beijing Tiantan Hospital

Recruiting

Allogeneic Mesenchymal Stem Cells for the Survivors of Ischemic Stroke Trial (ASSIST)

Ischemic Stroke

China
Beijing Immunochina Medical Science & Technology...

Recruiting

Safety and Efficacy Evaluation of IM83 CAR-T Cells for Patients With Advanced Liver Tumors

Liver Cancer

China
Acotec Scientific Co., Ltd
Beijing Tiantan Hospital

Recruiting

ACOART Intracranial ISR Pilot:Intracranial DCB in the Treatment of Intracranial In-stent Restenosis

Stroke | Intracranial Atherosclerosis

China
Beijing Immunochina Medical Science & Technology...

Recruiting

Clinical Study to Evaluate the Safety and Efficacy of IM21 CAR-T Cells in the Treatment of Elderly Patients With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

China
Beijing Tiantan Hospital
NeuroDawn Pharmaceutical Co., Ltd.

Completed

Y-3 Injection in the Treatment of Acute Ischemic Stroke Phase II Clinical Trial

Acute Ischemic Stroke

China
3D Medicines (Beijing) Co., Ltd.

Withdrawn

3D011-08 Monotherapy in Subjects With Advanced Solid Tumors

Solid Tumor, Adult

China

Clinical Trials Sponsored by Staidson (Beijing) Biopharmaceuticals Co., Ltd

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Taiwan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations